Testing effectiveness (Phase 2)Not Yet RecruitingNCT06055166
What this trial is testing
A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors
Who this might be right for
PARP Inhibitor for Esophageal Squamous Cell Carcinoma
Chongqing University Cancer Hospital 120